Daurismo 100 mg/1
glasdegib · TABLET, FILM COATED · Pfizer Laboratories Div Pfizer Inc
Daurismo (glasdegib) is an oral prescription tablet used to treat newly diagnosed acute myeloid leukemia in adult patients, often given along with low-dose chemotherapy. It works by blocking the hedgehog signaling pathway, which helps slow cancer cell growth.
Key Facts
- Brand Name
- Daurismo
- Generic Name
- glasdegib
- NDC Code (Product)
0069-1531- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210656
- Drug Class
- Hedgehog Pathway Inhibitor [EPC]
- Marketing Start
- 12/10/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Daurismo used for?
Daurismo (glasdegib) is an oral prescription tablet used to treat newly diagnosed acute myeloid leukemia in adult patients, often given along with low-dose chemotherapy. It works by blocking the hedgehog signaling pathway, which helps slow cancer cell growth.
Is Daurismo a controlled substance?
Daurismo is not classified as a controlled substance by the DEA.
What is the generic name for Daurismo?
The generic name for Daurismo is glasdegib. There are no other listed brand versions of glasdegib.
What is the NDC code for Daurismo 100 mg/1?
The NDC (National Drug Code) for Daurismo 100 mg/1 is 0069-1531, listed by Pfizer Laboratories Div Pfizer Inc.
Other Daurismo Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)